LifeStance Health Group, Inc. reports results for the quarter ended June 30 - Earnings Summary
LifeStance Health Group, Inc. reports results for the quarter ended June 30 - Earnings Summary
LifeStance Health Group, Inc. LFST.OQ reported quarterly adjusted earnings of 6 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of eleven analysts for the quarter was for earnings of 4 cents per share. Wall Street expected results to range from 3 cents to 8 cents per share.
Revenue rose 26.1% to $435.35 million from a year ago; analysts expected $414.58 million.
LifeStance Health Group, Inc.'s reported EPS for the quarter was 6 cents.
The company reported quarterly net income of $23.61 million.
LifeStance Health Group, Inc. shares had fallen by 3.2% this quarter and gained 47.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 64% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for LifeStance Health Group, Inc. is $13.00, about 20.2% above its last closing price of $10.37
This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.04 | 0.06 | Beat |
Mar. 31 2026 | 0.01 | 0.04 | Beat |
Dec. 31 2025 | 0.00 | 0.03 | Beat |
Sep. 30 2025 | -0.01 | 0.00 | Beat |